In vivo multimodal imaging of stem cell transplantation in a rodent model of Parkinson's disease

Journal of Neuroscience Methods

Volumn 183, Issue 2, 2009, Pages 141-148

  Jackson, Johanna ^a   Chapon, Catherine ^a   Jones, William ^a   Hirani, Ella ^b   Qassim, Abdullah ^a   Bhakoo, Kishore ^a  

^a MRC CLINICAL SCIENCES CENTRE   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Bimodal imaging; Mesenchymal; MRI; PET; Rat; Stem cell

Indexed keywords

IRON OXIDE; RACLOPRIDE C 11; RADIOLIGAND; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CELL FUNCTION; CELL LOSS; CHEMICAL LABELING; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC ACTIVITY; IMAGING; IN VIVO STUDY; MALE; NERVE CELL; NERVOUS SYSTEM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARACRINE SIGNALING; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT; RODENT; STEM CELL; STEM CELL TRANSPLANTATION;

ADULT STEM CELLS; ANIMALS; ANTIPSYCHOTIC AGENTS; CARBON ISOTOPES; DIAGNOSTIC IMAGING; DISEASE MODELS, ANIMAL; GLIAL FIBRILLARY ACIDIC PROTEIN; INDOLES; MAGNETIC RESONANCE IMAGING; MALE; OXIDOPAMINE; PARKINSONIAN DISORDERS; POSITRON-EMISSION TOMOGRAPHY; RACLOPRIDE; RATS; RATS, SPRAGUE-DAWLEY; STEM CELL TRANSPLANTATION; TIME FACTORS; TYROSINE 3-MONOOXYGENASE;

EID: 70049112659     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2009.06.022     Document Type: Article

References (52)

1. Bae J.S., Furuya S., Shinoda Y., Endo S., Schuchman E.H., Hirabayashi Y., et al. Neurodegeneration augments the ability of bone marrow-derived mesenchymal stem cells to fuse with Purkinje neurons in Niemann-Pick type C mice. Hum Gene Ther 16 (2005) 1006-1011
2. Bohn M.C. Motoneurons crave glial cell line-derived neurotrophic factor. Exp Neurol 190 (2004) 263-275
3. Brederlau A., Correia A.S., Anisimov S.V., Elmi M., Paul G., Roybon L., et al. Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: effect of in vitro differentiation on graft survival and teratoma formation. Stem Cells (Dayton, Ohio) 24 (2006) 1433-1440
4. Bulte J.W., Zhang S.C., van Gelderen P., Herynek V., Jordan E.K., Janssen C.H., et al. Magnetically labeled glial cells as cellular MR contrast agents. Acad Radiol 9 Suppl. 1 (2002) S148-S150
5. Caplan A.I., and Dennis J.E. Mesenchymal stem cells as trophic mediators. J Cell Biochem 98 (2006) 1076-1084
6. Chen J., Li Y., Wang L., Lu M., Zhang X., and Chopp M. Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats. J Neurol Sci 189 (2001) 49-57
7. Chen X., Katakowski M., Li Y., Lu D., Wang L., Zhang L., et al. Human bone marrow stromal cell cultures conditioned by traumatic brain tissue extracts: growth factor production. J Neurosci Res 69 (2002) 687-691
8. Dazzi F., and Horwood N.J. Potential of mesenchymal stem cell therapy. Curr Opin Oncol 19 (2007) 650-655
9. Fallahi-Sichani M., Soleimani M., Najafi S.M., Kiani J., Arefian E., and Atashi A. In vitro differentiation of cord blood unrestricted somatic stem cells expressing dopamine-associated genes into neuron-like cells. Cell Biol Int 31 (2007) 299-303
10. Fu Y.S., Cheng Y.C., Lin M.Y., Cheng H., Chu P.M., Chou S.C., et al. Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopaminergic neurons in vitro: potential therapeutic application for Parkinsonism. Stem Cells (Dayton, Ohio) 24 (2006) 115-124
11. Guo L., Yin F., Meng H.Q., Ling L., Hu-He T.N., Li P., et al. Differentiation of mesenchymal stem cells into dopaminergic neuron-like cells in vitro. Biomed Environ Sci 18 (2005) 36-42
12. Hirani E., Opacka-Juffry J., Gunn R., Khan I., Sharp T., and Hume S. Pindolol occupancy of 5-HT(1A) receptors measured in vivo using small animal positron emission tomography with carbon-11 labeled WAY 100635. Synapse 36 (2000) 330-341
13. Houston G.C., Hume S.P., Hirani E., Goggi J.L., and Grasby P.M. Temporal characterisation of amphetamine-induced dopamine release assessed with [11C]raclopride in anaesthetised rodents. Synapse 51 (2004) 206-212
14. Hume S.P., Myers R., Bloomfield P.M., Opacka-Juffry J., Cremer J.E., Ahier R.G., et al. Quantitation of carbon-11-labeled raclopride in rat striatum using positron emission tomography. Synapse 12 (1992) 47-54
15. Hume S.P., Opacka-Juffry J., Myers R., Ahier R.G., Ashworth S., Brooks D.J., et al. Effect of l-dopa and 6-hydroxydopamine lesioning on [11C]raclopride binding in rat striatum, quantified using PET. Synapse 21 (1995) 45-53
16. Inaji M., Okauchi T., Ando K., Maeda J., Nagai Y., Yoshizaki T., et al. Correlation between quantitative imaging and behavior in unilaterally 6-OHDA-lesioned rats. Brain Res 1064 (2005) 136-145
17. Ishida Y., Kawai K., Magata Y., Abe H., Yoshimoto M., Takeda R., et al. Alteration of striatal [11C]raclopride and 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine uptake precedes development of methamphetamine-induced rotation following unilateral 6-hydroxydopamine lesions of medial forebrain bundle in rats. Neurosci Lett 389 (2005) 30-34
18. Jendelova P., Herynek V., Urdzikova L., Glogarova K., Kroupova J., Andersson B., et al. Magnetic resonance tracking of transplanted bone marrow and embryonic stem cells labeled by iron oxide nanoparticles in rat brain and spinal cord. J Neurosci Res 76 (2004) 232-243
19. Josephson L., Tung C.H., Moore A., and Weissleder R. High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjug Chem 10 (1999) 186-191
20. Kirik D., Rosenblad C., and Bjorklund A. Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat. Exp Neurol 152 (1998) 259-277
21. Le Masurier M., Houston G., Cowen P., Grasby P., Sharp T., and Hume S. Tyrosine-free amino acid mixture attenuates amphetamine-induced displacement of [11C]raclopride in striatum in vivo: a rat PET study. Synapse 51 (2004) 151-157
22. Lee J.C., Cho G.S., Kim H.J., Lim J.H., Oh Y.K., Nam W., et al. Accelerated cerebral ischemic injury by activated macrophages/microglia after lipopolysaccharide microinjection into rat corpus callosum. Glia 50 (2005) 168-181
23. Li Y., Chen J., Wang L., Zhang L., Lu M., and Chopp M. Intracerebral transplantation of bone marrow stromal cells in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. Neurosci Lett 316 (2001) 67-70
24. Lu L., Zhao C., Liu Y., Sun X., Duan C., Ji M., et al. Therapeutic benefit of TH-engineered mesenchymal stem cells for Parkinson's disease. Brain Res Protoc 15 (2005) 46-51
25. Martino G., and Pluchino S. The therapeutic potential of neural stem cells. Nat Rev 7 (2006) 395-406
26. Mezey E., Chandross K.J., Harta G., Maki R.A., and McKercher S.R. Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science 290 (2000) 1779-1782
27. Myers R., Hume S., Bloomfield P., and Jones T. Radio-imaging in small animals. J Psychopharmacol (Oxford, England) 13 (1999) 352-357
28. Nasef A., Mathieu N., Chapel A., Frick J., Francois S., Mazurier C., et al. Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G. Transplantation 84 (2007) 231-237
29. Opydo-Chanek M. Bone marrow stromal cells in traumatic brain injury (TBI) therapy: true perspective or false hope?. Acta Neurobiol Exp (Wars) 67 (2007) 187-195
30. Ourednik J., Ourednik V., Lynch W.P., Schachner M., and Snyder E.Y. Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons. Nature Biotechnol 20 (2002) 1103-1110
31. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates: the coronal sections. 6 ed. (2006), Academic Press
32. Pellegrino D., Cicchetti F., Wang X., Zhu A., Yu M., Saint-Pierre M., et al. Modulation of dopaminergic and glutamatergic brain function: PET studies on parkinsonian rats. J Nucl Med 48 (2007) 1147-1153
33. Perese D.A., Ulman J., Viola J., Ewing S.E., and Bankiewicz K.S. A 6-hydroxydopamine-induced selective parkinsonian rat model. Brain Res 494 (1989) 285-293
34. Porada C.D., Zanjani E.D., and Almeida-Porad G. Adult mesenchymal stem cells: a pluripotent population with multiple applications. Curr Stem Cell Res Ther 1 (2006) 365-369
35. Redmond Jr. D.E., Bjugstad K.B., Teng Y.D., Ourednik V., Ourednik J., Wakeman D.R., et al. Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells. Proc Natl Acad Sci USA 104 (2007) 12175-12180
36. Robb R.A., and Hanson D.P. A software system for interactive and quantitative visualization of multidimensional biomedical images. Australas Phys Eng Sci Med 14 1 (1991) 9-30
37. Rosser A.E., Zietlow R., and Dunnett S.B. Stem cell transplantation for neurodegenerative diseases. Curr Opin Neurol 20 (2007) 688-692
38. Sanberg P.R. Neural stem cells for Parkinson's disease: to protect and repair. Proc Natl Acad Sci USA 104 (2007) 11869-11870
39. Sanchez-Ramos J.R. Neural cells derived from adult bone marrow and umbilical cord blood. J Neurosci Res 69 (2002) 880-893
40. Schwarting R.K., and Huston J.P. The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments. Prog Neurobiol 50 (1996) 275-331
41. Schwarting R.K., and Huston J.P. Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae. Prog Neurobiol 49 (1996) 215-266
42. Schwarz E.J., Alexander G.M., Prockop D.J., and Azizi S.A. Multipotential marrow stromal cells transduced to produce L-DOPA: engraftment in a rat model of Parkinson disease. Hum Gene Ther 10 (1999) 2539-2549
43. Snyder B.J., and Olanow C.W. Stem cell treatment for Parkinson's disease: an update for 2005. Curr Opin Neurol 18 (2005) 376-385
44. Song H., Stevens C.F., and Gage F.H. Astroglia induce neurogenesis from adult neural stem cells. Nature 417 (2002) 39-44
45. Suon S., Yang M., and Iacovitti L. Adult human bone marrow stromal spheres express neuronal traits in vitro and in a rat model of Parkinson's disease. Brain Res 1106 (2006) 46-51
46. Talbott J.F., Loy D.N., Liu Y., Qiu M.S., Bunge M.B., Rao M.S., et al. Endogenous Nkx2,2+/Olig2+ oligodendrocyte precursor cells fail to remyelinate the demyelinated adult rat spinal cord in the absence of astrocytes. Exp Neurol 192 (2005) 11-24
47. Teismann P., Tieu K., Cohen O., Choi D.K., Wu D.C., Marks D., et al. Pathogenic role of glial cells in Parkinson's disease. Mov Disord 18 (2003) 121-129
48. Visnyei K., Tatsukawa K.J., Erickson R.I., Simonian S., Oknaian N., Carmichael S.T., et al. Neural progenitor implantation restores metabolic deficits in the brain following striatal quinolinic acid lesion. Exp Neurol 197 (2006) 465-474
49. Weimann J.M., Charlton C.A., Brazelton T.R., Hackman R.C., and Blau H.M. Contribution of transplanted bone marrow cells to Purkinje neurons in human adult brains. Proc Natl Acad Sci USA 100 (2003) 2088-2093
50. Yang L., Xia Y., Zhao H., Zhao J., and Zhu X. Magnetic resonance imaging of transplanted neural stem cells in Parkinson disease rats. J Huazhong Univ Sci Technol Med Sci 26 (2006) 489-492
51. Zhang R.L., Zhang L., Zhang Z.G., Morris D., Jiang Q., Wang L., et al. Migration and differentiation of adult rat subventricular zone progenitor cells transplanted into the adult rat striatum. Neuroscience 116 (2003) 373-382
52. Zhao D.C., Lei J.X., Chen R., Yu W.H., Zhang X.M., Li S.N., et al. Bone marrow-derived mesenchymal stem cells protect against experimental liver fibrosis in rats. World J Gastroenterol 11 (2005) 3431-3440